Amantadine and cognitive flexibility: decision making in Parkinson’s patients with severe pathological gambling and other impulse control disorders

References

• ChaudhuriKRSchapiraAHNon-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatmentLancet Neurol20098546447419375664
   PubMed Web of Science ®Google Scholar
• VoonVFernagutPOWickensJChronic dopaminergic stimulation in Parkinson’s disease: from dyskinesias to impulse control disordersLancet Neurol20098121140114919909912
   PubMed Web of Science ®Google Scholar
• HousdenCRO’SullivanSSJoyceEMLeesAJRoiserJPIntact reward learning but elevated delay discounting in Parkinson’s disease patients with impulsive-compulsive spectrum behaviorsNeuropsychopharmacology201035112155216420631686
   PubMed Web of Science ®Google Scholar
• VillellaCMartinottiGDi NicolaMBehavioural addictions in adolescents and young adults: results from a prevalence studyJ Gambl Stud201127220321420559694
   PubMed Web of Science ®Google Scholar
• PietrzakRHPetryNMSeverity of gambling problems and psychosocial functioning in older adultsJ Geriatr Psychiatry Neurol200619210611316690996
   PubMed Web of Science ®Google Scholar
• MartinottiGAndreoliSGiamettaEPoliVBriaPJaniriLThe dimensional assessment of personality in pathologic and social gamblers: the role of novelty seeking and self-transcendenceCompr Psychiatry200647535035616905396
   PubMed Web of Science ®Google Scholar
• EvansAHKatzenschlagerRPaviourDPunding in Parkinson’s disease: its relation to the dopamine dysregulation syndromeMov Disord20041939740515077237
   PubMed Web of Science ®Google Scholar
• WeintraubDKoesterJPotenzaMNImpulse control disorders in Parkinson disease: a cross-sectional study of 3090 patientsArch Neurol20106758959520457959
   PubMed Web of Science ®Google Scholar
• ThomasABonanniLGambiFDi IorioAOnofrjMPathological gambling in Parkinson disease is reduced by amantadineAnn Neurol201068340040420687121
   PubMed Web of Science ®Google Scholar
• van EimerenTBallangerBPellecchiaGMiyasakiJMLangAEStrafellaAPDopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson’s disease?Neuropsychopharmacology200934132758276619741594
   PubMed Web of Science ®Google Scholar
• CiliaRChoSSvan EimerenTPathological gambling in patients with Parkinson’s disease is associated with fronto-striatal disconnection: a path modeling analysisMov Disord201126222523321284039
   PubMed Web of Science ®Google Scholar
• CiliaRKoJHChoSSReduced dopamine transporter density in the ventral striatum of patients with Parkinson’s disease and pathological gamblingNeurobiol Dis20103919810420338240
   PubMed Web of Science ®Google Scholar
• ReuterJRaedlerTRoseMHandIGläscherJBüchelCPathological gambling is linked to reduced activation of the mesolimbic reward systemNat Neurosci20058214714815643429
   PubMed Web of Science ®Google Scholar
• van HolstRJvan HolsteinMvan den BrinkWVeltmanDJGoudriaanAEResponse inhibition during cue reactivity in problem gamblers: an fMRI studyPloS One201273e3090922479305
   PubMed Web of Science ®Google Scholar
• BalodisIMKoberHWorhunskyPDStevensMCPearlsonGDPotenzaMNDiminished frontostriatal activity during processing of monetary rewards and losses in pathological gamblingBiol Psychiatry201271874975722336565
   PubMed Web of Science ®Google Scholar
• PotenzaMNShould addictive disorders include non-substance-related conditions?Addiction2006101Suppl 114215116930171
   PubMed Web of Science ®Google Scholar
• VitaleCSantangeloGTrojanoLComparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson’s diseaseMov Disord201126583083621370268
   PubMed Web of Science ®Google Scholar
• Silveira-MoriyamaLEvansAHKatzenschlagerRLeesAJPunding and dyskinesiasMov Disord200621122214221717013916
   PubMed Web of Science ®Google Scholar
• KalivasPWThe glutamate homeostasis hypothesis of addictionNat Rev Neurosci200910856157219571793
   PubMed Web of Science ®Google Scholar
• de la Fuente-FernándezRSossiVHuangZLevodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson’s disease: implications for dyskinesiasBrain2004127Pt 122747275415329355
   PubMed Web of Science ®Google Scholar
• PondalMMarrasCMiyasakiJClinical features of dopamine agonist withdrawal syndrome in a movement disorders clinicJ Neurol Neurosurg Psychiatry201384213013522933817
   PubMed Web of Science ®Google Scholar
• RabinakCANirenbergMJDopamine agonist withdrawal syndrome in Parkinson diseaseArch Neurol2010671586320065130
   PubMedGoogle Scholar
• CrosbyNJDeaneKHClarkeCEAmantadine for dyskinesia in Parkinson’s diseaseCochrane Database Syst Rev20032CD00346712804468
   PubMedGoogle Scholar
• ThomasAIaconoDLucianoALArmellinoKDi IorioAOnofrjMDuration of amantadine benefit on dyskinesia of severe Parkinson’s diseaseJ Neurol Neurosurg Psychiatry200475114114314707325
   PubMed Web of Science ®Google Scholar
• AllersKABergstromDAGhaziLJKreissDSWaltersJRMK801 and amantadine exert different effects on subthalamic neuronal activity in a rodent model of Parkinson’s diseaseExp Neurol2005191110411815589517
   PubMed Web of Science ®Google Scholar
• MoreauCDelvalATiffreauVMemantine for axial signs in Parkinson’s disease: a randomised, double-blind, placebo-controlled pilot studyJ Neurol Neurosurg Psychiatry201384555255523077087
   PubMed Web of Science ®Google Scholar
• RabeyJMNissipeanuPKorczynADEfficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson’s diseaseJ Neural Transm Park Dis Dement Sect199242772821388698
   PubMedGoogle Scholar
• Verhagen MetmanLBlanchetPJvan den MunckhofPDel DottoPNattéRChaseTNA trial of dextromethorphan in parkinsonian patients with motor response complicationsMov Disord19981334144179613730
   PubMed Web of Science ®Google Scholar
• MartinottiGAndreoliSGiamettaEPoliVBriaPJaniriLThedimensional assessment of personality in pathologic and social gamblers: the role of novelty seeking and self-transcendenceCompr Psychiatry200647535035616905396
   PubMed Web of Science ®Google Scholar
• ChenYCHolmesAEffects of topiramate and other anti-glutamatergic drugs on the acute intoxicating actions of ethanol in mice: modulation by genetic strain and stressNeuropsychopharmacology20093461454146618843265
   PubMed Web of Science ®Google Scholar
• OnofrjMLucianoALIaconoDHLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson’s diseaseMov Disord200318333734012621640
   PubMed Web of Science ®Google Scholar
• HughesAJDanielSEKilfordLLeesAJAccuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 casesJ Neurol Neurosurg Psychiatry19925531811841564476
   PubMed Web of Science ®Google Scholar
• WeintraubDMamikonyanEPapayKSheaJAXieSXSiderowfAQuestionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease-Rating ScaleMov Disord201227224224722134954
   PubMed Web of Science ®Google Scholar
• LesieurHRBlumeSBThe South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblersAm J Psychiatry1987144118411883631315
   PubMed Web of Science ®Google Scholar
• FahnSEltonRLMembers of the Unified Parkinson’s Disease Rating Scale Development CommitteeUnified Parkinson’s disease rating scaleFahnSMarsdenCDCalneDBGoldsteinMRecent Development in Parkinson’s Disease2Florham Park, NJMacmillan Healthcare Information1987153164
   Google Scholar
• HoehnMMYahrMDParkinsonism: onset, progression and mortalityNeurology1967174274426067254
   PubMed Web of Science ®Google Scholar
• FolsteinNFFolsteinSEMcHughPR“Mini-mental state”: a practical method for grading the cognitive state of patients for clinicianJ Psychiatry Res197512189198
   PubMed Web of Science ®Google Scholar
• Limbrick-OldfieldEHvan HolstRJClarkLFronto-striatal dysregulation in drug addiction and pathological gambling: Consistent inconsistencies?Neuroimage Clin2013238539324179792
   PubMed Web of Science ®Google Scholar
• StroopJRStudies of interference in serial verbal reactionsJ Exp Psychol193518643662
   Google Scholar
• MacLeodCMHalf a century of research on the Stroop effect: an integrative reviewPsychol Bull19911091632032034749
   PubMed Web of Science ®Google Scholar
• BentallRPKaneySContent specific information processing and persecutory delusions: an investigation using the emotional Stroop testBr J Med Psychol1989623553642597651
   PubMed Web of Science ®Google Scholar
• NewmanJPEffects of characterological anxiety and situational arousal on the solving of a color-word interference task: hemispheric processing implicationsInt J Neurosci1990521–2192265916
   PubMed Web of Science ®Google Scholar
• EidePKempASilbersteinRBNathanPJStoughCTest-retest reliability of the emotional stroop task: examining the paradox of measurement changeJ Psychol2002136551452012431035
   PubMed Web of Science ®Google Scholar
• PettorrusoMMartinottiGDi NicolaMAmantadine in the treatment of pathological gambling: a case reportFront Psychiatry2012310223205015
   PubMedGoogle Scholar
• KertzmanSLidogosterHAizerAKotlerMDannonPNRisk-taking decisions in pathological gamblers is not a result of their impaired inhibition abilityPsychiatry Res20111881717721429591
   PubMed Web of Science ®Google Scholar
• SantangeloGVitaleCTrojanoLVerdeFGrossiDBaronePCognitive dysfunctions and pathological gambling in patients with Parkinson’s diseaseMov Disord20092489990519205072
   PubMed Web of Science ®Google Scholar
• SiriCCiliaRDe GaspariDCognitive status of patients with Parkinson’s disease and pathological gamblingJ Neurol2010257224725219727901
   PubMed Web of Science ®Google Scholar
• CothranDLLarsenRComparison of inhibition in two timed reaction tasks: the color and emotion Stroop tasksJ Psychol2008142437338518792649
   PubMed Web of Science ®Google Scholar
• CohenJDDunbarKMcClellandJLOn the control of automatic processes: a parallel distributed processing account of the Stroop effectPsychol Rev19909733323612200075
   PubMed Web of Science ®Google Scholar
• WilliamsJMThe emotional Stroop task and psychopathologyPsychol Bull19961203248711015
   PubMed Web of Science ®Google Scholar
• PrattoFJohnOPAutomatic vigilance: the attention-grabbing power of negative social informationJ Pers Soc Psychol19916133803911941510
   PubMed Web of Science ®Google Scholar
• WeintraubDSohrMSiderowfAAmantadine use associated with impulse control disorders in Parkinson diseaseAnn Neurol2006637969973
   Google Scholar
• WangOKilpatrickRDCritchlowCWRelationship between epoetin alfa dose and mortality: findings from a marginal structural modelClin J Am Soc Nephrol2010518218820019122
   PubMed Web of Science ®Google Scholar
• FahnSThe history of dopamine and levodopa in the treatment of Parkinson’s diseaseMov Disord200823Suppl 3S497S50818781671
   PubMed Web of Science ®Google Scholar
• WalshRALangAEMultiple impulse control disorders developing in Parkinson’s disease after initiation of amantadineMov Disord201227232621954056
   PubMedGoogle Scholar
• MestreTAStrafellaAPThomsenTVoonVMiyasakiJDiagnosis and treatment of impulse control disorders in patients with movement disordersTher Adv Neurol Disord20136317518823634190
   PubMed Web of Science ®Google Scholar
• SprengerFPoeweWManagement of motor and non-motor symptoms in Parkinson’s diseaseCNS Drugs201327425927223515972
   PubMed Web of Science ®Google Scholar